NEFRX vs. LGRCX
Compare and contrast key facts about Loomis Sayles Core Plus Bond Fund (NEFRX) and Loomis Sayles Growth Fund Class C (LGRCX).
NEFRX is managed by Natixis. It was launched on Nov 7, 1973. LGRCX is managed by Natixis. It was launched on Feb 1, 2013.
Performance
NEFRX vs. LGRCX - Performance Comparison
Loading graphics...
NEFRX vs. LGRCX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NEFRX Loomis Sayles Core Plus Bond Fund | -0.38% | 7.24% | 0.60% | 5.91% | -12.94% | -1.68% | 10.29% | 8.76% | -0.86% | 4.92% |
LGRCX Loomis Sayles Growth Fund Class C | -11.85% | 12.90% | 33.77% | 49.68% | -28.62% | 17.50% | 30.41% | 30.47% | -3.53% | 31.39% |
Returns By Period
In the year-to-date period, NEFRX achieves a -0.38% return, which is significantly higher than LGRCX's -11.85% return. Over the past 10 years, NEFRX has underperformed LGRCX with an annualized return of 2.28%, while LGRCX has yielded a comparatively higher 14.27% annualized return.
NEFRX
- 1D
- 0.26%
- 1M
- -1.88%
- YTD
- -0.38%
- 6M
- 0.27%
- 1Y
- 3.58%
- 3Y*
- 3.15%
- 5Y*
- 0.05%
- 10Y*
- 2.28%
LGRCX
- 1D
- 3.76%
- 1M
- -6.13%
- YTD
- -11.85%
- 6M
- -12.50%
- 1Y
- 10.22%
- 3Y*
- 18.06%
- 5Y*
- 9.91%
- 10Y*
- 14.27%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
NEFRX vs. LGRCX - Expense Ratio Comparison
NEFRX has a 0.71% expense ratio, which is lower than LGRCX's 1.65% expense ratio.
Return for Risk
NEFRX vs. LGRCX — Risk / Return Rank
NEFRX
LGRCX
NEFRX vs. LGRCX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Loomis Sayles Core Plus Bond Fund (NEFRX) and Loomis Sayles Growth Fund Class C (LGRCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NEFRX | LGRCX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.98 | 0.53 | +0.44 |
Sortino ratioReturn per unit of downside risk | 1.42 | 0.98 | +0.44 |
Omega ratioGain probability vs. loss probability | 1.18 | 1.13 | +0.05 |
Calmar ratioReturn relative to maximum drawdown | 2.22 | -0.18 | +2.40 |
Martin ratioReturn relative to average drawdown | 7.31 | -0.53 | +7.83 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| NEFRX | LGRCX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.98 | 0.53 | +0.44 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.01 | 0.45 | -0.44 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.46 | 0.69 | -0.23 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.73 | 0.48 | +0.25 |
Correlation
The correlation between NEFRX and LGRCX is -0.02. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.
Dividends
NEFRX vs. LGRCX - Dividend Comparison
NEFRX's dividend yield for the trailing twelve months is around 3.63%, more than LGRCX's 3.51% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NEFRX Loomis Sayles Core Plus Bond Fund | 3.63% | 3.97% | 3.90% | 3.58% | 3.10% | 2.34% | 4.04% | 2.51% | 2.87% | 2.68% | 3.17% | 2.58% |
LGRCX Loomis Sayles Growth Fund Class C | 3.51% | 3.10% | 7.70% | 8.01% | 21.28% | 5.81% | 5.14% | 2.60% | 6.05% | 2.18% | 1.36% | 0.00% |
Drawdowns
NEFRX vs. LGRCX - Drawdown Comparison
The maximum NEFRX drawdown since its inception was -25.45%, smaller than the maximum LGRCX drawdown of -58.53%. Use the drawdown chart below to compare losses from any high point for NEFRX and LGRCX.
Loading graphics...
Drawdown Indicators
| NEFRX | LGRCX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -25.45% | -58.53% | +33.08% |
Max Drawdown (1Y)Largest decline over 1 year | -3.12% | -18.16% | +15.04% |
Max Drawdown (5Y)Largest decline over 5 years | -18.55% | -35.31% | +16.76% |
Max Drawdown (10Y)Largest decline over 10 years | -18.76% | -35.31% | +16.55% |
Current DrawdownCurrent decline from peak | -2.57% | -14.91% | +12.34% |
Average DrawdownAverage peak-to-trough decline | -3.97% | -11.13% | +7.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.95% | 8.05% | -7.10% |
Volatility
NEFRX vs. LGRCX - Volatility Comparison
The current volatility for Loomis Sayles Core Plus Bond Fund (NEFRX) is 1.52%, while Loomis Sayles Growth Fund Class C (LGRCX) has a volatility of 6.48%. This indicates that NEFRX experiences smaller price fluctuations and is considered to be less risky than LGRCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| NEFRX | LGRCX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 1.52% | 6.48% | -4.96% |
Volatility (6M)Calculated over the trailing 6-month period | 2.85% | 12.97% | -10.12% |
Volatility (1Y)Calculated over the trailing 1-year period | 4.99% | 25.32% | -20.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 6.20% | 23.06% | -16.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 5.02% | 21.10% | -16.08% |